ASC-US
Clinical trials for ASC-US explained in plain language.
Never miss a new study
Get alerted when new ASC-US trials appear
Sign up with your email to follow new studies for ASC-US, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo aims to clear persistent HPV infection
Disease control Recruiting nowThis early-stage trial tests two vaccines designed to help the immune system fight HPV16, a virus linked to cervical cancer. The study includes 30 women with persistent HPV16 infection and mild cervical cell changes (ASC-US or LSIL). Participants receive a DNA vaccine followed by…
Matched conditions: ASC-US
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a vaginal suppository clear High-Risk HPV?
Disease control Recruiting nowThis study tests whether a vaginal suppository called Dysplasix can help women clear high-risk human papillomavirus (HPV) and reverse low-grade cervical abnormalities. About 45 women with HPV and mild cervical changes will use the suppository or a placebo for 19 days. Researchers…
Matched conditions: ASC-US
Phase: PHASE2 • Sponsor: Amplexd Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC